We’re proud to announce that HitChem will be participating in the 2025 Discovery on Target (DOT) Conference, one of the industry’s most respected forums for showcasing target-based drug discovery strategies.

Date: September 22-25

Location: Sheraton Boston Hotel, Boston, MA

Don’t miss our featured presentation:"scovering Novel CRBN Molecular Glue Degraders through Integrated Generative AI and Lab Chemistry Capabilities”

️ September 24, 2:55 – 3:10 PM

Degraders & Molecular Glues – Part 2 Session

‍ Speaker: Dr. Hongbo Zhang, VP & Head of Drug Discovery, HitChem

As the drug discovery landscape rapidly evolves, Discovery on Target provides an invaluable opportunity for sharing innovations in target identification and lead generation

At HitChem, we’re committed to enabling more effective early-stage discovery through our rationally designed compound libraries, and AI-guided hit-to-lead computational chemistry expertise. We’re excited to engage with fellow scientists and collaborators who are driving innovation in therapeutic development.

Stop by our booth to speak with our team, explore partnership opportunities, and discover how our technology is helping researchers make smarter, faster drug development.

We look forward to connecting with you in Boston!